Search By Initial

Cas Index 1

• 131740-09-5 | Flavopiridol(Alvocidib) (Catalog# : 52310)Flavopiridol HCl competes with ATP to inhibit CDKs includingCDK1,CDK2,CDK4andCDK6with
• 1206161-97-8 | Filgotinib (Catalog# : 51612)Filgotinib (GLPG0634) is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM
• 1260907-17-2 | GSK 525762A (Catalog# : 171459)
• 133052-90-1 | GF-109203X (Catalog# : L20356)GF-109203X is a potent and highly selective PCK inhibitor, which inhibits PKC isozyme
• 1258292-64-6 | GDC-046 (Catalog# : L20342)GDC-046 is a potent, selective, and orally bioavailable TYK2 inhibitor for TYK2, JAK1
• 1831144-46-7 | GDC-0214 (Catalog# : c20341)iJak-381 is a highly potent, selective, and inhalable Janus kinase-1 (JAK-1) inhibito
• 106740-09-4 | GYY4137 (Catalog# : L20339)GYY4137 is a novel water-soluble and slow releasing H2S donor. Hydrogen sulfide (H2S)
• 1139889-93-2 | Golgicide A (Catalog# : 20292)Golgicide A is a Potent, selective and reversible inhibitor of GBF1 ArfGEF. Golgicide
• 113852-41-8 | GS 0573 ( PMEDAP ) (Catalog# : 20275)GS 0573 is an antiviral compound that has been studied for potential treatment of Fel
• 1953133-47-5 | Giredestrant (Catalog# : 21248)Giredestrant, also known as GDC-9545 and RG6171, is a SERD. GDC-9545 is an orally ava
• 1652591-81-5 | GSK484 HCl (Catalog# : 20111801)GSK484 is a potent PAD-4 inhibitor (Protein-arginine deiminase type-4). GSK484 potent
• 1093070-16-6 | GRL0617 (Catalog# : 2071625)GRL0617 is a potent, selective and competitive noncovalent inhibitor of SARS PLPro. G
• 1191237-69-0 | GS-441524 (Catalog# : 2071546)GS-441524 is a potent inhibitor of feline infectious peritonitis (FIP) virus with an
• 1622849-43-7 | GSK3145095 (Catalog# : 2071533)GSK3145095 is a potent and orally active RIPK1 inhibitor (IC50 = 5 nM) with potential
• 1629063-81-5 | GNE-131 (Catalog# : 2071509)GNE-131 is a Potent and Selective hNaV1.7 Inhibitor (Na V1.7 IC50 = 3 nM) for the Tre
• 1642581-63-2 | Glumetinib (Catalog# : 203401)Glumetinib, also known as SCC244, is a novel, potent and highly selective inhibitor o
• 1394121-05-1 | GNE-2861 (Catalog# : 111892)GNE-2861 is a potent and exquisitely kinase-selective Group II PAK inhibitor (PAK4 Ki
• 1549811-53-1 | GSK-199 (Catalog# : 193293)GSK199 is a selective PAD4 inhibitor with half-maximum inhibitory concentration (IC50
• 1637770-13-8 | GS-626510 (Catalog# : 193221)GS-626510 is a potent BET family bromodomains inhibitor. It acts by targeting BRD2/3/
• 1445879-21-9 | GSK2837808A (Catalog# : 193194)GSK2837808A is a potent, selective lactate dehydrogenase A (LDHA) inhibitor (IC50 val
• 1536200-31-3 | GNE-9605 (Catalog# : 192284)GNE-9605 is a highly potent, selective, and brain-penetrant aminopyrazole leucine-ric
• 1227911-45-6 | GSK2334470 (Catalog# : 192224)GSK2334470 is a potent 3-phosphoinositide-dependent protein kinase (PDK1) inhibitor (
• 1032754-81-6 | GNE-477 (Catalog# : 192181)GNE-477, a potent and efficacious dual PI3K/mTOR inhibitor.
• 1373422-53-7 | GSKJ1 (Catalog# : 191255)GSKJ1 is a selective and potent histone demethylase inhibitor (GSK-J1) that has signi
• 1150701-66-8 | GSK1940029 (Catalog# : 1812102)GSK1940029, also known as SCD Inhibitor 1, is a SCD Inhibitor. GSK1940029 is a potent
• 1420367-28-7 | GSK2814338 (Catalog# : 181241)GSK2814338, also known as Lp-PLA2 -IN-1, is a Lp-PLA2 inhibitor.
• 1642297-01-5 | GDC-0927 (Catalog# : 1811301)GDC-0927, also known as SRN-927, is a next-generation oral SERD which appears to have
• 1923851-49-3 | GSK9311 (Catalog# : 1811233)GSK9311 is a potent and highly selective inhibitor of the BRPF bromodomain (BRPDF1 pI
• 1404456-53-6 | GSK-2830371 (Catalog# : 1810292)GSK 2830371 is a WiP1 inhibitor. It inhibits cell growth and tumor growth in lymphoma
• 1196541-47-5 | GDC-0575 (Catalog# : 189272)GDC-0575 (ARRY-575, RG7741) is a potent and selective CHK1 inhibitor with an IC50 of